Frank Rösl

Frank Rösl


Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 1997 in Journal of Virology
Verified
Journal Article
Closed access
PDF file
FRFrank Rösl
Frank Rösl
BDB C Das
B C Das
MLM Lengert
M Lengert
KGK Geletneky
K Geletneky
HHH Zur Hausen
H Zur Hausen
Considering the involvement of a redox-regulatory pathway in the expression of human papillomaviruses (HPVs), HPV type 16 (HPV-16)-immortalized human keratinocytes were treated with the antioxidant pyrrolidine-dithiocarbamate (PDTC). PDTC induces elevated binding of the transcription factor AP-1 to its cognate recognition site within the viral regulatory region. Despite of increased AP-1 binding, normally indispensable for efficient HPV-16 transcription, viral gene expression was selectively suppressed at the level of initiation of transcription. Electrophoretic mobility supershift assays showed that the composition of the AP-1 complex, predominantly consisting of Jun homodimers in untreated cells, was altered. Irrespective of enhanced c-fos expression, c-jun was phosphorylated and became primarily heterodimerized with fra-1, which was also induced after PDTC incubation. Additionally, there was also an increased complex formation between c-jun and junB. Because both fra-1 and junB overexpression negatively interferes with c-jun/c-fos trans-activation of AP-1-responsive genes, our results suggest that the observed block in viral transcription is mainly the consequence of an antioxidant-induced reconstitution of the AP-1 transcription complex. Since expression of the c-jun/c-fos gene family is tightly regulated during cellular differentiation, defined reorganization of a central viral transcription factor may represent a novel mechanism controlling the transcription of pathogenic HPVs during keratinocyte differentiation and in the progression to cervical cancer.

10 June 2011 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
FHFlorianne E Henken
Florianne E Henken
NBNilam Sanjib Banerjee
Nilam Sanjib Banerjee
PSPeter Jf Snijders
Peter Jf Snijders
CMChris Jlm Meijer
Chris Jlm Meijer
JAJohanna De-Castro Arce
Johanna De-Castro Arce
Renske D.M. SteenbergenRenske D.M. Steenbergen
Renske D.M. Steenbergen
Background: High-risk human papillomavirus (hrHPV) infections are causally related to cervical cancer development. The additional (epi)genetic alterations driving malignant transformation of hrHPV-infected cells however, are not yet fully elucidated. In this study we experimentally assessed the role of the PI3-kinase pathway and its regulator PIK3CA, which is frequently altered in cervical cancer, in HPV-induced transformation. Methods: Cervical carcinomas and ectocervical controls were assessed for PIK3CA mRNA and protein expression by quantitative RT-PCR and immunohistochemical staining, respectively. A longitudinal in vitro model system of hrHPV-transfected keratinocytes, representing the immortal and anchorage independent phenotype, was assayed for PI3-kinase activation and function using chemical pathway inhibition i.e. LY294002 treatment, and PIK3CA RNA interference. Phenotypes examined included cellular viability, migration, anchorage independent growth and differentiation. mRNA expression of hTERT and HPV16 E6E7 were studied using quantitative RT-PCR and Northern blotting. Results: Cervical carcinomas showed significant overexpression of PIK3CA compared to controls. During HPV-induced transformation in vitro, expression of the catalytic subunit PIK3CA as well as activation of downstream effector PKB/AKT progressively increased in parallel. Inhibition of PI3-kinase signalling in HPV16-transfected keratinocytes by chemical interference or siRNA-mediated silencing of PIK3CA resulted in a decreased phosphorylation of PKB/AKT. Moreover, blockage of PI3-kinase resulted in reduced cellular viability, migration, and anchorage independent growth. These properties were accompanied with a downregulation of HPV16E7 and hTERT mRNA expression. In organotypic raft cultures of HPV16- and HPV18-immortalized cells, phosphorylated PKB/AKT was primarily seen in differentiated cells staining positive for cytokeratin 10 (CK10). Upon PI3-kinase signalling inhibition, there was a severe impairment in epithelial tissue development as well as a dramatic reduction in p-PKB/AKT and CK10. Conclusion: The present data indicate that activation of the PI3-kinase/PKB/AKT pathway through PIK3CA regulates various transformed phenotypes as well as growth and differentiation of HPV-immortalized cells and may therefore play a pivotal role in HPV-induced carcinogenesis.

29 May 1998 in International Journal of Cancer
Verified
Journal Article
Closed access
PDF file
TMToshiyuki Maehama
Toshiyuki Maehama
APAndrea Patzelt
Andrea Patzelt
MLMaike Lengert
Maike Lengert
KHKarl-Josef Hutter
Karl-Josef Hutter
KKKoji Kanazawa
Koji Kanazawa
FRFrank Rösl
Frank Rösl

15 June 2000 in International Journal of Cancer
Verified
Journal Article
Closed access
PDF file
USUbaldo Soto
Ubaldo Soto
CDClaudia Denk
Claudia Denk
PFPatrick Finzer
Patrick Finzer
KHKarl‐Josef Hutter
Karl‐Josef Hutter
HHHarald Zur Hausen
Harald Zur Hausen
FRFrank Rösl
Frank Rösl

24 April 2019 in mSphere
Verified
Journal Article
Open access
PDF file
RYRuwen Yang
Ruwen Yang
JKJana Klimentová
Jana Klimentová
EGElke Göckel-Krzikalla
Elke Göckel-Krzikalla
RLRegina Ly
Regina Ly
NGNadine Gmelin
Nadine Gmelin
MNMartina Niebler
Martina Niebler
Human papillomavirus (HPV)-associated cancers still remain a big health problem, especially in developing countries, despite the availability of prophylactic vaccines. Although HPV oncogenes have been intensively investigated for decades, a study applying recent advances in RNA-Seq and quantitative proteomic approaches to a precancerous model system with well-defined HPV oncogene expression alongside HPV-negative parental cells has been missing until now. Here, combined omics analyses reveal global changes caused by the viral oncogenes in a less biased way and allow the identification of novel factors and key cellular networks potentially promoting malignant transformation. In addition, this system also provides a basis for mechanistic research on novel key factors regulated by HPV oncogenes, especially those that are confirmed in vivo in cervical cancer as well as in head and neck cancer patient samples from TCGA data sets.

1 July 2015 in Experimental Cell Research
Verified
Journal Article
Closed access
MRMoises Ramos-Solano
Moises Ramos-Solano
IMIvan David Meza-Canales
Ivan David Meza-Canales
LTLuis A. Torres-Reyes
Luis A. Torres-Reyes
MZMonserrat Álvarez zavala
Monserrat Álvarez zavala
LALiliana Alvarado-Ruíz
Liliana Alvarado-Ruíz
Adriana Aguilar-LemarroyAdriana Aguilar-Lemarroy
Adriana Aguilar-Lemarroy